JWZ-5-13
JWZ-5-13 is a potent CDK7 PROTAC degrader that significantly degrades CDK7 via the ubiquitin-proteasome system. JWZ-5-13 has antitumor activity. (Pink: Target protein ligand (HY-161830) ; Black: linker (HY-Y0925) ; Blue: E3 ligase ligand (HY-112078) ) [1].
Product Specifications
CAS Number
[3103763-70-5]
UNSPSC
12352005
Target
CDK; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jwz-5-13.html
Purity
98.19
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C54H66N10O6S
Molecular Weight
983.23
References & Citations
[1]Ji W, et al. Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7) . Eur J Med Chem. 2024 Jun 27;276:116613.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PTK/PI 3-K/mTOR Inhibitor, PP121 (1-Cyclopentyl-3- (1H-pyrrolo[2,3-b]pyridin-5-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine, PI 3-K Inhibitor XIII, PI 3-K/mTOR Inhibitor II, VEGFR Tyrosine Kinase Inhibitor XXXII, VEGFR2 Kinase Inhibitor XXX, mTOR Inhibitor VII, Abl Inhibitor IV)